Login
Startbase author

Marc Nemitz

Recent articles by Marc Nemitz

News Differential Bio secures €2 million pre-seed The Munich-based AI biotech start-up Differential Bio is emerging from stealth mode. The virtual scale-up platform aims to make bio-based production processes more efficient and scalable.
News PSD Bank Braunschweig relies on financial education app from Finstep GenZ as a service. How PSD Bank Braunschweig wants to strengthen financial literacy with an app.
News fiskaly takes over Deutsche Fiskal New merger in the FinTech sector. Through the acquisition, fiskaly bundles expertise and strengthens its market position.
News Altris receives investment from Volvo Cars Tech Fund Volvo Cars participates in the Altris financing round. The aim is to jointly develop energy storage systems with sodium-ion batteries.
News specter automation receives 5 million euros for 3D construction site management Investors focus on digitalization in the construction industry. specter automation raises over 5 million euros to make construction projects more efficient.
News Unsuccessful constitutional complaint against solidarity surcharge No end to the solidarity surcharge! The Federal Constitutional Court has rejected the constitutional complaint against the solidarity surcharge. A bitter decision, especially for entrepreneurs and start-ups.
News GravitHy closes EUR 60 million financing Steel production with green hydrogen . GravitHy is planning a new plant in France that will produce two million tons of low-carbon iron per year by 2028.
News AMBOSS receives 240 million euros AMBOSS is strengthening its position as digital support for doctors worldwide. With a new financing round of 240 million euros, the company intends to grow further.
News mo:re receives 2.3 million euros for automated laboratory platform With seed funding of € 2.3 million, the start-up is driving forward the commercialization and standardization of animal-free methods.
News Hubble Therapeutics closes USD 7.3 million Series A financing The funds will be used for the further clinical development of the gene therapy HUB-101, which focuses on rare eye diseases such as LCA16.

FYI: English edition available

Hello my friend, have you been stranded on the German edition of Startbase? At least your browser tells us, that you do not speak German - so maybe you would like to switch to the English edition instead?

Go to English edition

FYI: Deutsche Edition verfügbar

Hallo mein Freund, du befindest dich auf der Englischen Edition der Startbase und laut deinem Browser sprichst du eigentlich auch Deutsch. Magst du die Sprache wechseln?

Deutsche Edition öffnen